The feline injection-site sarcoma (FIS) is a challenge for the veterinarian and the affected cat`s owner. The injectable applications (vaccines, medications) seems to be the reason for that neoplasia, more specifically, the inflammation caused by injury of given drugs or antigens to the health tissue. Generally the FIS presents a more aggressive behavior when compared to sarcoma not associated to application. The most effective treatment his not been established yet, but it is believed that a multimodality of therapies, surgery, radiotherapy, and chemotherapy would be the most indicated option. The knowledge of the illness in all of its aspects will Supply to professionals colleges subsidies in relation to the best way to approach its diagn...
Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chro...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
The feline injection-site sarcoma (FIS) is a challenge for the veterinarian and the affected cat`s o...
Feline injection-site sarcoma (FISS) is a highly aggressive and malignant tumour of mesenchymal orig...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
Abstract Feline injection-site sarcomas (FISS) are malignant skin tumours of mesenchymal origin, the...
Corey F Saba Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Univer...
ABSTRACT Feline Injection Site-Associated Sarcoma (FISS) is a neoplasm that implies in reduction of ...
Within the past two decades, feline injection-site sarcomas have been recognized as a group of invas...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
Feline injection – site sarcomas (FISS) are aggressively behaving fibrosarcomas with a rate of metas...
Injection-site sarcomas are a relatively common type of cancer in cats with an estimated incidence o...
OVERVIEW: In cats, the most serious of adverse effects following vaccination is the occurrence of in...
Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chro...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
The feline injection-site sarcoma (FIS) is a challenge for the veterinarian and the affected cat`s o...
Feline injection-site sarcoma (FISS) is a highly aggressive and malignant tumour of mesenchymal orig...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
Abstract Feline injection-site sarcomas (FISS) are malignant skin tumours of mesenchymal origin, the...
Corey F Saba Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, Univer...
ABSTRACT Feline Injection Site-Associated Sarcoma (FISS) is a neoplasm that implies in reduction of ...
Within the past two decades, feline injection-site sarcomas have been recognized as a group of invas...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
Feline injection – site sarcomas (FISS) are aggressively behaving fibrosarcomas with a rate of metas...
Injection-site sarcomas are a relatively common type of cancer in cats with an estimated incidence o...
OVERVIEW: In cats, the most serious of adverse effects following vaccination is the occurrence of in...
Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chro...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...